Bioavailability and bioequivalence: An FDA regulatory overview Other Scholarly Work

Chen, ML, Shah, V, Patnaik, R et al. (2001). Bioavailability and bioequivalence: An FDA regulatory overview . PHARMACEUTICAL RESEARCH, 18(12), 1645-1650. 10.1023/A:1013319408893

cited authors

  • Chen, ML; Shah, V; Patnaik, R; Adams, W; Hussain, A; Conner, D; Mehta, M; Malinowski, H; Lazor, J; Huang, SM; Hare, D; Lesko, L; Sporn, D; Williams, R

sustainable development goals

authors

publication date

  • December 1, 2001

webpage

published in

keywords

  • ABSORPTION
  • Abbreviated New Drug Applications
  • CMAX
  • Chemistry
  • Chemistry, Multidisciplinary
  • Life Sciences & Biomedicine
  • New Drug Applications
  • Pharmacology & Pharmacy
  • Physical Sciences
  • SIMULATIONS
  • SINGLE
  • Science & Technology
  • bioavailability
  • bioequivalence
  • generic drugs
  • guidances

Digital Object Identifier (DOI)

publisher

  • KLUWER ACADEMIC/PLENUM PUBL

start page

  • 1645

end page

  • 1650

volume

  • 18

issue

  • 12